Invention Grant
- Patent Title: Compounds as receptor modulators with therapeutic utility
- Patent Title (中): 化合物作为具有治疗效用的受体调节剂
-
Application No.: US14071534Application Date: 2013-11-04
-
Publication No.: US08703746B2Publication Date: 2014-04-22
- Inventor: Todd M. Heidelbaugh , Phong X. Nguyen
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A61K31/67
- IPC: A61K31/67 ; A61K31/4178 ; A61K31/443 ; A61K31/4439 ; A61K31/665 ; A61K31/675 ; A61P1/00 ; A61P9/10 ; A61P11/00 ; A61P11/06 ; A61P17/02 ; A61P17/06 ; A61P17/18 ; A61P19/02 ; A61P19/04 ; A61P19/08 ; A61P19/10 ; A61P25/00 ; A61P25/28 ; A61P27/02 ; A61P27/06 ; A61P29/00 ; A61P35/04 ; A61P37/00 ; A61P37/06 ; A61P37/08
Abstract:
The present invention relates to novel derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20140057876A1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY Public/Granted day:2014-02-27
Information query
